Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2019

30.08.2019 | Original Article

Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate

verfasst von: Maryan Cavicchi, Gaëlle Tharsis, Pascal Burtin, Philippe Cattan, Franck Venezia, Gilles Tordjman, Agnès Gillet, Joëlle Samama, Karine Nahon-Uzan, David Karsenti

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Adenoma detection rate (ADR) is correlated with the risk of interval colorectal cancer and is considered as a quality benchmark for colonoscopy. Serrated polyp detection rate (SPDR) might be a more stringent indicator of quality in polyp detection.

Aims

To evaluate in a 2-year monocentric observational study patient-dependent and endoscopist-dependent factors influencing ADR and SPDR in daily practice.

Methods

We determined ADR and SPDR. We collected patient-dependent factors and endoscopist-dependent factors. Links between these data and detection rates were assessed by uni- and multivariate analysis.

Results

A total of 11682 colonoscopies were performed (female: 54.3%; male: 45.7%; median age 58) by 30 endoscopists (female: 9; male: 21). ADR and SPDR were 29.2% and 8%, respectively. In multivariate analysis, ADR was associated with patient-dependent factors: age (OR 1.044, CI 95% 1.040–1.048), male gender (OR 1.7, CI 95% 1.56–1.85), personal history of polyp/cancer (OR 1.53, CI 95% 1.3–1.9), and positive fecal immunochemical test (OR 2.47, CI 95% 2.0–3.1). In multivariate analysis, SPDR was associated with withdrawal time (OR 1.25, CI 95% 1.17–1.32), low volume activity (OR 1.3, CI 95% 1.1–1.52), and personal history of polyp/cancer (OR 1.61, CI 95% 1.15–2.25).

Conclusion

In this large series of routine colonoscopies, we found that ADR was mainly driven by patient-dependent conditions, i.e., age, male gender, colonoscopy indication for positive FIT, and a personal history of polyp or cancer. In contrast, SPDR was mainly related to endoscopist-dependent factor, i.e., withdrawal time and low volume activity.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics 2012. CA Cancer J Clin. 2015;65:87–108.PubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics 2012. CA Cancer J Clin. 2015;65:87–108.PubMed
2.
Zurück zum Zitat Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.PubMed Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.PubMed
3.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981.PubMed Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981.PubMed
4.
Zurück zum Zitat Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.PubMed Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.PubMed
5.
Zurück zum Zitat Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–1680.PubMed Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–1680.PubMed
6.
Zurück zum Zitat Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.PubMed Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.PubMed
7.
Zurück zum Zitat Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomized controlled trials and observational studies. BMJ. 2014;348:g2467.PubMedPubMedCentral Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomized controlled trials and observational studies. BMJ. 2014;348:g2467.PubMedPubMedCentral
8.
Zurück zum Zitat Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedPubMedCentral
9.
Zurück zum Zitat Niikura R, Hirata Y, Suzuki N, Yamada A, et al. Colonoscopy reduces colorectal cancer mortality: a multicenter, long-term, colonoscopy-based cohort study. PLoS ONE. 2017;28(12):e0185294. Niikura R, Hirata Y, Suzuki N, Yamada A, et al. Colonoscopy reduces colorectal cancer mortality: a multicenter, long-term, colonoscopy-based cohort study. PLoS ONE. 2017;28(12):e0185294.
10.
Zurück zum Zitat Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.PubMed Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.PubMed
11.
Zurück zum Zitat Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the italian randomized controlled trial—SCORE. J Natl Cancer Inst. 2011;103:1310–1322.PubMed Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the italian randomized controlled trial—SCORE. J Natl Cancer Inst. 2011;103:1310–1322.PubMed
12.
Zurück zum Zitat Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–2357.PubMedPubMedCentral Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–2357.PubMedPubMedCentral
13.
Zurück zum Zitat Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312:606–615.PubMedPubMedCentral Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312:606–615.PubMedPubMedCentral
14.
Zurück zum Zitat Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017;49:378–397.PubMed Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017;49:378–397.PubMed
15.
Zurück zum Zitat Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMed Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMed
16.
Zurück zum Zitat Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.PubMedPubMedCentral Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.PubMedPubMedCentral
17.
Zurück zum Zitat Wieszczy P, Regula J, Kaminski MF. Adenoma detection rate and risk of colorectal cancer. Best Pract Res Clin Gastroenterol. 2017;31:441–446.PubMed Wieszczy P, Regula J, Kaminski MF. Adenoma detection rate and risk of colorectal cancer. Best Pract Res Clin Gastroenterol. 2017;31:441–446.PubMed
18.
Zurück zum Zitat Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105.PubMed Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105.PubMed
19.
Zurück zum Zitat Ross WA, Thirumurthi S, Lynch PM, et al. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? Gastrointest Endosc. 2015;81:567–574.PubMedPubMedCentral Ross WA, Thirumurthi S, Lynch PM, et al. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? Gastrointest Endosc. 2015;81:567–574.PubMedPubMedCentral
20.
Zurück zum Zitat Floer M, Meister T. Endoscopic improvement of the adenoma detection rate during colonoscopy—where do we stand in 2015. Digestion. 2016;93:202–213.PubMed Floer M, Meister T. Endoscopic improvement of the adenoma detection rate during colonoscopy—where do we stand in 2015. Digestion. 2016;93:202–213.PubMed
21.
Zurück zum Zitat Anderson JC, Butterly LF, Weiss JE, Robinson CM. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017;85:1188–1194.PubMedPubMedCentral Anderson JC, Butterly LF, Weiss JE, Robinson CM. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017;85:1188–1194.PubMedPubMedCentral
22.
Zurück zum Zitat IJspeert JE, van Doorn SC, van der Brug YM, Bastiaansen BA, Fockens P, Dekker E. The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps. Gastrointest Endosc. 2015;82:870–877.PubMed IJspeert JE, van Doorn SC, van der Brug YM, Bastiaansen BA, Fockens P, Dekker E. The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps. Gastrointest Endosc. 2015;82:870–877.PubMed
23.
Zurück zum Zitat Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139(1503–10):1510.e1–1510.e3. Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139(1503–10):1510.e1–1510.e3.
24.
Zurück zum Zitat Calderwood AH, Jacobson BC. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc. 2010;72:686–692.PubMedPubMedCentral Calderwood AH, Jacobson BC. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc. 2010;72:686–692.PubMedPubMedCentral
25.
Zurück zum Zitat Arditi C, Peytremann-Bridevaux I, Burnand B, et al. EPAGE II Study Group. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy. 2009;41:200–208.PubMed Arditi C, Peytremann-Bridevaux I, Burnand B, et al. EPAGE II Study Group. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy. 2009;41:200–208.PubMed
26.
Zurück zum Zitat Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–1329.PubMedPubMedCentral Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–1329.PubMedPubMedCentral
27.
Zurück zum Zitat Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255.PubMedPubMedCentral Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255.PubMedPubMedCentral
28.
Zurück zum Zitat Cairns SR, Scholefiels JH, Steele RJ, et al. Guidelines pour colorectal cancer screenin and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–689.PubMed Cairns SR, Scholefiels JH, Steele RJ, et al. Guidelines pour colorectal cancer screenin and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–689.PubMed
29.
Zurück zum Zitat Lee TJ, Rutter MD, Blanks RG, et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut. 2012;61:1050–1057.PubMed Lee TJ, Rutter MD, Blanks RG, et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut. 2012;61:1050–1057.PubMed
30.
Zurück zum Zitat Coe SG, Wallace MB. Assessment of adenoma detection rate benchmarks in women versus men. Gastrointest Endosc. 2013;77:631–635.PubMed Coe SG, Wallace MB. Assessment of adenoma detection rate benchmarks in women versus men. Gastrointest Endosc. 2013;77:631–635.PubMed
31.
Zurück zum Zitat Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients From the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153:307–323.PubMed Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients From the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153:307–323.PubMed
32.
Zurück zum Zitat Park JH, Kim SJ, Hyun JH, et al. Correlation between bowel preparation and the adenoma detection rate in screening colonoscopy. Ann Coloproctol. 2017;33:93–98.PubMedPubMedCentral Park JH, Kim SJ, Hyun JH, et al. Correlation between bowel preparation and the adenoma detection rate in screening colonoscopy. Ann Coloproctol. 2017;33:93–98.PubMedPubMedCentral
33.
Zurück zum Zitat Kashiwagi K, Inoue N, Yoshida T, et al. Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy. PLoS ONE. 2017;12:e0174155.PubMedPubMedCentral Kashiwagi K, Inoue N, Yoshida T, et al. Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy. PLoS ONE. 2017;12:e0174155.PubMedPubMedCentral
34.
Zurück zum Zitat Jung Y, Joo YE, Kim HG, et al. Relationship between the endoscopic withdrawal time and adenoma/polyp detection rate in individual colonic segments: a KASID multicenter study. Gastrointest Endosc. 2019;89:523–530.PubMed Jung Y, Joo YE, Kim HG, et al. Relationship between the endoscopic withdrawal time and adenoma/polyp detection rate in individual colonic segments: a KASID multicenter study. Gastrointest Endosc. 2019;89:523–530.PubMed
35.
Zurück zum Zitat Lee TJ, Blanks RG, Rees CJ, et al. Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England. Endoscopy. 2013;45:20–26.PubMed Lee TJ, Blanks RG, Rees CJ, et al. Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England. Endoscopy. 2013;45:20–26.PubMed
36.
Zurück zum Zitat Vavricka SR, Sulz MC, Degen L, et al. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy. 2016;48:256–262.PubMed Vavricka SR, Sulz MC, Degen L, et al. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy. 2016;48:256–262.PubMed
37.
Zurück zum Zitat Shaukat A, Rector TS, Church TR, et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology. 2015;149:952–957.PubMed Shaukat A, Rector TS, Church TR, et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology. 2015;149:952–957.PubMed
40.
Zurück zum Zitat Sanaka MR, Rai T, Navaneethan U, et al. Adenoma detection rate in high-risk patients differs from that in average-risk patients. Gastrointest Endosc. 2016;83:172–178.PubMed Sanaka MR, Rai T, Navaneethan U, et al. Adenoma detection rate in high-risk patients differs from that in average-risk patients. Gastrointest Endosc. 2016;83:172–178.PubMed
41.
Zurück zum Zitat Martínez ME, Baron JA, Lieberman DA, et al. A Pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–841.PubMed Martínez ME, Baron JA, Lieberman DA, et al. A Pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–841.PubMed
42.
Zurück zum Zitat Ijspeert JE, de Wit K, van der Vlugt M, Bastiaansen BA, Fockens P, Dekker E. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy. 2016;48:740–746.PubMed Ijspeert JE, de Wit K, van der Vlugt M, Bastiaansen BA, Fockens P, Dekker E. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy. 2016;48:740–746.PubMed
43.
Zurück zum Zitat O’Connell B, Hafiz N, Crockett S. The serrated polyp pathway: is it time to alter surveillance guidelines? Curr Gastroenterol Rep. 2017;19:52.PubMedPubMedCentral O’Connell B, Hafiz N, Crockett S. The serrated polyp pathway: is it time to alter surveillance guidelines? Curr Gastroenterol Rep. 2017;19:52.PubMedPubMedCentral
44.
Zurück zum Zitat Butterly L, Robinson CM, Anderson JC, et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol. 2014;109:417–426.PubMedPubMedCentral Butterly L, Robinson CM, Anderson JC, et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol. 2014;109:417–426.PubMedPubMedCentral
45.
Zurück zum Zitat Crockett SD, Gourevitch RA, Morris M, et al. Endoscopist factors that influence serrated polyp detection: a multicenter study. Endoscopy. 2018;50:984–992.PubMedPubMedCentral Crockett SD, Gourevitch RA, Morris M, et al. Endoscopist factors that influence serrated polyp detection: a multicenter study. Endoscopy. 2018;50:984–992.PubMedPubMedCentral
47.
Zurück zum Zitat Do A, Weinberg J, Kakkar A, Jacobson BC. Reliability of adenoma detection rate si based on procedural volume. Gastrointest Endosc. 2013;77:376–380.PubMed Do A, Weinberg J, Kakkar A, Jacobson BC. Reliability of adenoma detection rate si based on procedural volume. Gastrointest Endosc. 2013;77:376–380.PubMed
48.
Zurück zum Zitat Occhipinti P, Saettone S, Cristina S, Ridola L, Hassan C. Correlation between adenoma and serrated lesion detection rates in an unselected outpatient population. Dig Liver Dis. 2015;47:508–511.PubMed Occhipinti P, Saettone S, Cristina S, Ridola L, Hassan C. Correlation between adenoma and serrated lesion detection rates in an unselected outpatient population. Dig Liver Dis. 2015;47:508–511.PubMed
49.
Zurück zum Zitat East JE, Atkin WS, Bateman AC, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66:1181–1196.PubMed East JE, Atkin WS, Bateman AC, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66:1181–1196.PubMed
50.
Zurück zum Zitat Shin A, Hong CW, Sohn DK, et al. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol. 2011;174:552–562.PubMed Shin A, Hong CW, Sohn DK, et al. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol. 2011;174:552–562.PubMed
51.
Zurück zum Zitat Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–772.PubMed Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–772.PubMed
52.
Zurück zum Zitat Kanadiya MK, Gohel TD, Sanaka MR, Thota PN, Shubrook JH Jr. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complic. 2013;27:463–466. Kanadiya MK, Gohel TD, Sanaka MR, Thota PN, Shubrook JH Jr. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complic. 2013;27:463–466.
53.
Zurück zum Zitat Jung YS, Park CH, Eun CS, Park DI, Han DS. Statin use and the risk of colorectal adenoma: a meta-analysis. J Gastroenterol Hepatol. 2016;31:1823–1830.PubMed Jung YS, Park CH, Eun CS, Park DI, Han DS. Statin use and the risk of colorectal adenoma: a meta-analysis. J Gastroenterol Hepatol. 2016;31:1823–1830.PubMed
54.
Zurück zum Zitat Jung YS, Park CH, Eun CS, Park DI, Han DS. Metformin use and the risk of colorectal adenoma: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:957–965.PubMed Jung YS, Park CH, Eun CS, Park DI, Han DS. Metformin use and the risk of colorectal adenoma: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:957–965.PubMed
55.
Zurück zum Zitat Lebwohl B, Capiak K, Neugut AI, Kastrinos F. Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy. Aliment Pharmacol Ther. 2012;35:1467–1473.PubMedPubMedCentral Lebwohl B, Capiak K, Neugut AI, Kastrinos F. Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy. Aliment Pharmacol Ther. 2012;35:1467–1473.PubMedPubMedCentral
Metadaten
Titel
Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate
verfasst von
Maryan Cavicchi
Gaëlle Tharsis
Pascal Burtin
Philippe Cattan
Franck Venezia
Gilles Tordjman
Agnès Gillet
Joëlle Samama
Karine Nahon-Uzan
David Karsenti
Publikationsdatum
30.08.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05808-y

Weitere Artikel der Ausgabe 12/2019

Digestive Diseases and Sciences 12/2019 Zur Ausgabe

PROFILES AND PERSPECTIVES

DDS Profile: Maria T. Abreu, MD

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.